This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Acuo Recognized By KLAS For VNA Market Leadership In The United Kingdom

Stocks in this article: LXK









MAIDENHEAD, United Kingdom, May 28, 2013 /PRNewswire/ -- Acuo Technologies®, a world leader in high-performance software and services for clinical content management and data migration and now part of Lexmark's Perceptive Software, announced today that KLAS recently released the results of a Performance Report entitled "PACS in the U.K." that names Acuo as the "independent VNA frontrunner."

PACS replacement activity is high in the U.K. as regional contracts with healthcare trusts begin to come up for renewal. As part of the PACS replacement initiative, many providers are also implementing vendor neutral archives (VNAs) to improve interoperability of clinical content across disparate healthcare facilities, departments and data silos. Of providers surveyed in the KLAS report that are considering a VNA, Acuo received the most "first choice" votes.     

The KLAS report went on to say that Acuo has "an advantage because they already have won several significant VNA tenders in the U.K." These tenders include selection as the national VNA platform for Wales and regional NHS Trust consortiums in Sussex and Surrey, Salisbury, Wight and South Hampshire (SWASH), North Bristol, Doncaster and Gloucester. KLAS reported that only 6% of those interviewed in the study already have a VNA in place. Acuo's regional experience and momentum positions the company as a strong contender for new VNA selections in the U.K. and mainland Europe in the months to come.     

Acuo often works with PACS vendors, data storage vendors and other healthcare IT partners as part of a comprehensive clinical content management solution, including migration of clinical data to and from PACS archives. Acuo's Universal Clinical Platform provides a comprehensive solution for clinical abstraction and life cycle management of all diagnostic images and related content, including an integrated XDS registry and repository embedded within the VNA.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,471.37 -207.33 -1.17%
S&P 500 2,036.82 -20.27 -0.99%
NASDAQ 4,707.2080 -64.5550 -1.35%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs